| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 17170375
[patent_doc_number] => 20210324045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => BULLFROG SKIN-DERIVED COLLAGEN, MATERIALS COMPRISING THEREOF, AND APPLICATIONS IN WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 17/233022
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233022 | BULLFROG SKIN-DERIVED COLLAGEN, MATERIALS COMPRISING THEREOF, AND APPLICATIONS IN WOUND HEALING | Apr 15, 2021 | Pending |
Array
(
[id] => 17140326
[patent_doc_number] => 20210308337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING HEALING AND REGENERATION OF BONE AND SOFT TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/230023
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230023 | COMPOSITIONS AND METHODS FOR ENHANCING HEALING AND REGENERATION OF BONE AND SOFT TISSUE | Apr 13, 2021 | Pending |
Array
(
[id] => 17480615
[patent_doc_number] => 20220088119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/226996
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226996 | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE | Apr 8, 2021 | Abandoned |
Array
(
[id] => 19299973
[patent_doc_number] => 20240228542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/914303
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914303 | LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND METHODS OF MAKING AND USING SAME | Mar 25, 2021 | Pending |
Array
(
[id] => 18558721
[patent_doc_number] => 11723946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Methods for regulating transcription of multiple genes and expression of multiple targets
[patent_app_type] => utility
[patent_app_number] => 17/212951
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 8352
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212951 | Methods for regulating transcription of multiple genes and expression of multiple targets | Mar 24, 2021 | Issued |
Array
(
[id] => 16946715
[patent_doc_number] => 20210205406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/207222
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207222
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207222 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18310534
[patent_doc_number] => 20230114434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/906177
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -114
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906177 | EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS | Mar 14, 2021 | Pending |
Array
(
[id] => 17022293
[patent_doc_number] => 20210246164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/198285
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198285 | PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF | Mar 10, 2021 | Pending |
Array
(
[id] => 17355403
[patent_doc_number] => 20220016199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/184745
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184745 | HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18243057
[patent_doc_number] => 20230075368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => IDENTIFICATION OF AN EGFR-BIN3 PATHWAY THAT ACTIVELY SUPPRESSES INVASION AND REDUCES TUMOR SIZE IN GLIOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 17/800210
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800210 | IDENTIFICATION OF AN EGFR-BIN3 PATHWAY THAT ACTIVELY SUPPRESSES INVASION AND REDUCES TUMOR SIZE IN GLIOBLASTOMA | Feb 18, 2021 | Pending |
Array
(
[id] => 18212052
[patent_doc_number] => 20230058316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => PEGYLATED IGE-DEPENDENT HISTAMINE-RELEASING FACTOR (HRF)-BINDING PEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/793369
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793369 | PEGYLATED IGE-DEPENDENT HISTAMINE-RELEASING FACTOR (HRF)-BINDING PEPTIDE AND USE THEREOF | Jan 31, 2021 | Pending |
Array
(
[id] => 18565834
[patent_doc_number] => 20230256161
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-08-17
[patent_title] => Methods and Compositions for Treating a Disease Condition in a Subject
[patent_app_type] => utility
[patent_app_number] => 17/141876
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141876 | Methods and Compositions for Treating a Disease Condition in a Subject | Jan 4, 2021 | Abandoned |
Array
(
[id] => 18565834
[patent_doc_number] => 20230256161
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-08-17
[patent_title] => Methods and Compositions for Treating a Disease Condition in a Subject
[patent_app_type] => utility
[patent_app_number] => 17/141876
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141876 | Methods and Compositions for Treating a Disease Condition in a Subject | Jan 4, 2021 | Abandoned |
Array
(
[id] => 16822741
[patent_doc_number] => 20210138034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS
[patent_app_type] => utility
[patent_app_number] => 17/129303
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129303 | TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS | Dec 20, 2020 | Abandoned |
| 17/104864 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | Nov 24, 2020 | Pending |
Array
(
[id] => 17243464
[patent_doc_number] => 20210363207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SELECTIVE MCL-1 BINDING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/102427
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102427 | SELECTIVE MCL-1 BINDING PEPTIDES | Nov 22, 2020 | Abandoned |
Array
(
[id] => 16806123
[patent_doc_number] => 20210128676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 AND LOW MEAN ARTERIAL PRESSURE
[patent_app_type] => utility
[patent_app_number] => 17/083409
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083409 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 AND LOW MEAN ARTERIAL PRESSURE | Oct 28, 2020 | Abandoned |
Array
(
[id] => 16656098
[patent_doc_number] => 20210052734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PEPTIDE-MEDIATED INTRAVESICAL DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/080300
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080300 | PEPTIDE-MEDIATED INTRAVESICAL DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS | Oct 25, 2020 | Pending |
Array
(
[id] => 17625593
[patent_doc_number] => 20220160608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PEPTIDE FOR REDUCING HAIR LOSS AND PROMOTING HAIR GROWTH, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/436424
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436424 | PEPTIDE FOR REDUCING HAIR LOSS AND PROMOTING HAIR GROWTH, AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Oct 7, 2020 | Abandoned |
Array
(
[id] => 18034655
[patent_doc_number] => 20220378870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => A composition for boosting the immune system
[patent_app_type] => utility
[patent_app_number] => 17/767056
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767056 | A composition for boosting the immune system | Oct 6, 2020 | Pending |